AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ESOMEPRAZOLE & DOMPERIDONE
9 registrations across 4 African markets— 7 active
Markets with ESOMEPRAZOLE & DOMPERIDONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Esofag D Capsules** Capsule | 🇳🇬Nigeria | Micro Nova Pharmaceuticals Ind Ltd | active | Apr 2028 |
| Kesprid Tablet Tablet | 🇳🇬Nigeria | Kayhelt Pharma Limited | active | Dec 2026 |
| NEUESOME-D 40MG CAPSULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | AHAAN HEALTHCARE PVT LTD | active | Aug 2026 |
| ESOFAG_D 40/30MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2025 |
| NO-REFLUX 40MG/30MG GELULE BOITE DE 20 | 🇨🇮Côte d'Ivoire | PRODIPHARM | expired | Jan 2021 |
| S-DOM gélule / 40 mg /30 mg | 🇸🇳Senegal | AURA LIFECARE PVT LTD | active | — |
| ESOREZ-D 40MG/10MG GELULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | ZRENIE HEALTHCARE PVT LTD | active | — |
| NEUESOME D gélule / 40 mg / 30 mg | 🇸🇳Senegal | AHAAN HEALTHCARE PVT LTD | active | — |
| NEUESOME D gélule / 40 mg / 30 mg | 🇸🇳Senegal | AHAAN HEALTHCARE PVT LTD | active | — |
ESOMEPRAZOLE & DOMPERIDONE in Africa — Regulatory Overview
ESOMEPRAZOLE & DOMPERIDONE is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal, Nigeria, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 7 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.